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Diesel particulate matter (DPM) comprises a 
collection of minute substances generated by 
vehicular traffic that contribute substantially to 
particulate matter (PM) air pollution charac-
teristic of urban areas. The diameter of DPM 
is directly related to its biological properties, 
and PM, including DPM, with aerodynamic 
diameters ≤ 10 and 2.5 µm are classified as 
PM10 and PM2.5, respectively (Churg and 
Brauer 1997). Although PM10 can penetrate 
deep into the respiratory tree, PM2.5 can easily 
reach alveolar parenchymal cells and can be 
internalized by alveolar epithelium and mac-
rophages (Churg and Brauer 1997; Kim et al. 
1994). Inhalation of DPM has been associated 
with a host of cardiovascular and respiratory 
diseases, such as asthma, chronic obstructive 
pulmonary disease (COPD), and pulmonary 
fibrosis, which all contribute to significant 
morbidity and mortality (Bayram et al. 2006; 
Dockery et al. 1993; Hales et al. 2000; Harre 
et al. 1997). Of note, epidemiological studies 
have revealed remarkable associations between 
PM content in ambient air and increased rates 
of respiratory disease in susceptible popula-
tions (Dockery et al. 1993; Pope et al. 1995). 
Despite this current knowledge, it remains 
unclear which components in PM air pollu-
tion are responsible for adverse respiratory 
effects and which mechanisms are directly 
involved (Dreher 2000).
Receptors for advanced glycation end-
products (RAGE) are members of an immuno-
globin superfamily of cell-surface proteins 
expressed by many cell types, including smooth 
muscle cells, fibroblasts, macrophages and 
monocytes, and epithelial cells (Demling et al. 
2006; Thornally 1998). RAGE expression is 
most abundant in well-differentiated alveolar 
type I (ATI) cells in the lung (Schmidt et al. 
2001). Identification in alveolar epithelial cells 
has led to the implication of RAGE in impor-
tant developmental processes such as morpho-
logical differentiation and increased adherence 
that characterize the transitioning of cuboidal 
surfactant-secreting ATII cells to squamous 
ATI cells (Buckley and Ehrhardt 2010). RAGE 
was first described as a transmembrane pro-
tein that acts as a progression factor in cellular 
responses induced by advanced glycation end-
products (AGEs) that accumulate in hypergly-
cemia and oxidant stress (Schmidt et al. 1992). 
AGEs are stable chemical entities generated 
when simple sugars form amide linkages with 
amines on proteins, with further oxidant-in-
duced molecular rearrangement via Maillard 
chemistry. The result is a group of chemical 
structures that can bind and activate RAGE 
(Schmidt et al. 1992). Other studies have iden-
tified endogenous ligands such as cytokine-like 
mediators of the S100/calgranulin family of 
calcium-binding proteins, amyloid β-peptide, 
and HMGB-1 (high mobility group box 1, or 
amphoterin). These ligands orchestrate changes 
in gene expression via a host of activated signal 
transduction pathways (Hofmann et al. 1999; 
Taguchi et al. 2000; Yan et al. 1996). Research 
to date culminates in the characterization of 
RAGE as a pattern recognition receptor capa-
ble of recognizing and binding a collection of 
molecules with variable yet related geometry.
RAGE expression increases as its ligand 
availability elevates (Schmidt et al. 2001), and 
RAGE-ligand interaction leads to pathologi-
cal processes, including those associated with 
diabetic complications, neurodegenerative 
disorders, atherosclerosis, and inflammation 
(Hofmann et al. 1999; Taguchi et al. 2000). 
Despite known instances where RAGE is up-
regulated in disease, the full extent of RAGE 
expression and the molecular mechanisms 
that regulate its expression and subsequent 
downstream effects have not been adequately 
evaluated. Understanding the potential role 
of RAGE in the context of PM exposure 
could provide insights into the mechanisms 
of PM-induced pulmonary inflammation 
and provide opportunities for the reduction 
of PM-induced exacerbations common to 
chronic lung disease (Dockery et al. 1993; 
Ling and van Eden 2009; Schwartz 1995).
In the present study, we tested the 
hypothesis that pulmonary epithelial cells 
induce RAGE after exposure to DPM, a spe-
cific constituent of air pollution PM. We also 
tested the hypothesis that RAGE is directly 
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involved in generating a proinflammatory 
state in epithelial cells after DPM exposure. 
Using rat R3/1 cells, an immortalized ATI 
cell line, and human primary distal airspace 
epithelium, we demonstrated that RAGE 
is up-regulated after exposure to DPM and 
that nuclear factor-κB (NF-κB)–mediated 
cytokine secretion occurs via RAGE signaling. 
Collectively, these data offer novel insights 
into potential mechanisms whereby RAGE 
influences inflammation in pulmonary epi-
thelial cells after exposure to DPM.
Materials and Methods
Cell culture and DPM. R3/1 cells kindly 
provided by M. Kasper (Dresden University, 
Dresden, Germany) are derived from rat and 
are characteristic of ATI cells (Koslowski 
et al. 2004). R3/1 cells were maintained 
in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal calf 
serum (FCS), l-glutamine, and penicillin-
  streptomycin (Sigma, St. Louis, MO). 
Small airway epithelial cells (SAECs; Lonza 
Inc., Walkersville, MD) are human primary 
pulmonary epithelial cells isolated from 
distal airspaces; they were maintained in saline-
  adenine-  glucose-mannitol medium supple-
mented according to the supplier’s instructions. 
Cells were grown to 80–90% confluence and 
exposed to media supplemented with DPM 
or media alone for 2 hr. At the termination of 
the experiment, cells were treated in one of the 
following ways: immediately fixed for immu-
nocytochemistry, lysed before RNA isolation 
for assessment by real-time reverse transcriptase 
polymerase chain reaction (RT-PCR), or lysed 
and subjected to immunoblot analysis.
DPM used in these experiments is cata-
loged at the National Institute of Standards 
and Technology (NIST) as Standard Reference 
Material (SRM) 2975; DPM used to pre-
pare SRM 2975 (M.E. Wright, Donaldson 
Company, Inc., Minneapolis, MN) was col-
lected from a filtering system designed spe-
cifically for diesel-powered forklifts (Wright 
et al. 1991). DPM was homogenized and 
extracted for preparation of SRM 2975 and 
SRM 1975 (National Institute of Standards 
and Technology 2000). DPM-supplemented 
cell culture medium was prepared by adding 
appropriate weights of DPM to phosphate-
buffered saline (PBS). The resulting suspen-
sion was vigorously vortexed just before being 
added to freshly prepared DMEM plus 10% 
FCS media. Preliminary studies included 
DPM-supplemented media at concentrations 
that ranged from 1 to 50 µg/mL. The experi-
ments described in the present investigation all 
involved exposure to 3 µg/mL DPM for 2 hr 
to determine DPM effects in ambient settings.
RNA isolation and assessment by real-
time RT-PCR. Total RNA was isolated 
from R3/1 cells using the Absolutely RNA 
RT-PCR Miniprep Kit (Stratagene, La Jolla, 
CA). After total RNA was spectrophotomet-
rically quantified, reverse transcription and 
PCR amplification using a One-step Brilliant 
SYBR Green quantitative RT-PCR master 
mix kit (Stratagene) were performed in a 
single reaction following the manufacturer’s 
instructions. cDNA conversion, amplifica-
tion, and data analysis were performed using 
a Mx3000P real-time PCR system comput-
erized cycler (Stratagene). The following 
primers available through Primer Bank (ID 
no. 6671525a3) were synthesized and high-
performance liquid chromatography purified 
by Invitrogen Life Technologies (Carlsbad, 
CA): RAGE (forward, ACT ACC GAG TCC 
GAG TCT ACC; reverse, GTA GCT TCC 
CTC AGA CAC ACA) and glyceraldehyde 
3-phosphate dehydrogenase gene (GAPDH; 
forward, TAT GTC GTG GAG TCT ACT 
GGT; reverse, GAG TTG TCA TAT TTC 
TCG TGG). Primers were used at a concen-
tration of 75 nM each in 25-µL reactions. 
Cycle parameters included 40 min at 55°C 
for reverse transcription and then 10 min at 
95°C and 40 cycles of 30 sec at 95°C, 1 min 
at 58°C, and 30 sec at 72°C. Control samples 
lacking template or RT were included to iden-
tify primer-dimer products and to exclude 
possible contaminants. Data are presented as 
percent change normalized to GAPDH.
Protein isolation and immunoblot analy-
sis. Total protein was isolated from R3/1 cells 
using RIPA buffer and associated protease 
inhibitors (Santa Cruz Biotechnology, Santa 
Cruz, CA). Protein concentrations were deter-
mined by bicinchoninic acid assay to ensure 
equal loading for assessment by sodium dode-
cyl sulfate–polyacrylamide gel electrophoresis 
(SDS-PAGE). Briefly, 20 µg total protein 
was separated by SDS-PAGE, transferred 
to a nitrocellulose membrane, and blocked 
with 5% nonfat milk. The membrane was 
incubated with a primary RAGE polyclonal 
antibody (R&D Systems, Minneapolis, MN) 
diluted at 1:1,000 at 4°C overnight. Exposure 
to HRP-conjugated secondary anti  bodies 
(Thermo Fisher Scientific, Rockford, IL) 
was followed by development with electro-
chemiluminescence (Amersham Biosciences, 
Buckinghamshire, UK). Immunoblotting 
images presented here are representative of 
three experiments, and densitometric evalua-
tion of the bands was conducted using 
UN-SCAN-IT gel densitizing software (Silk 
Scientific, Orem, UT). Density data were 
standardized to small interfering control RNA 
(siControl)–transfected cells and set to 1.
Immunohistochemistry. Cells in select 
experiments were fixed by incubation in 4% 
paraformaldehyde for 20 min and then washed 
in three changes of PBS before assessment 
of active NF-κB by immunocytochemistry. 
Staining was conducted as generally outlined 
(Reynolds et al. 2008) by using a primary 
antibody against active NF-κB (NF-κB p65 
monoclonal antibody; Cell Signaling, Beverly, 
MA) at a concentration of 1:50 and a donkey 
anti-rabbit secondary antibody (Santa Cruz). 
Control cultures were incubated in blocking 
serum alone. Individuals blinded to the type of 
small interfering RNA (siRNA) transfected and 
the presence or absence of DPM performed 
three counts of 100 cells in each experiment. 
Cells with > 50% immunoreactivity in the 
cytoplasm or nucleus were considered cyto-
plasmic or nuclear positive for NF-κB, respec-
tively. Cells with an equal cytosolic/nuclear 
distribution of NF-κB were not considered. 
Total cells from the three counts were averaged, 
and standard deviations were determined.
siRNA and vector transfection and reporter 
gene assays. As outlined in select experiments, 
R3/1 or SAECs were transfected with rat 
or human siRNA for RAGE (siRAGE) or a 
scrambled control siRNA sequence (siControl) 
generated by Santa Cruz 24 hr before DPM 
exposure. siRNA transfections were performed 
using the recommended transfection reagent 
mix (Santa Cruz). Functional assays of reporter 
gene constructs were performed by transient 
transfection of R3/1 cells grown to 40–50% 
confluence. Cells were transfected with 500 ng 
pRSV-βgal to determine transfection efficiency 
and 100 ng pNF-κB–Luc vector (Stratagene) 
or pcDNA control vector to bring total DNA 
concentration to 600 ng. Cells were allowed to 
grow 24 hr before exposure to DPM or fresh 
medium replacement. After 2 hr of DPM 
exposure, cells were washed and lysed, and 
cleared supernatant was used for both β-gal 
and luciferase assays. Reporter assays were nor-
malized for transfection efficiency based on 
β-gal assays performed as previously described 
(Reynolds et al. 2004). Luciferase activity was 
determined in 10 µL extract at room tempera-
ture with 100 µL luciferase reagent (Promega 
Corporation, Madison, WI) for 10 sec after a 
2-sec delay in a Monoight 3010 luminometer 
(BD Biosciences, Franklin Lakes, NJ).
Measurement of cytokine levels. Enzyme-
linked immunosorbent assay (ELISA) was used 
to assess the concentration of cytokines secreted 
by R3/1 cells. Briefly, media were removed 
before cell lysis, and equal volumes of cell cul-
ture media were assessed in each experimental 
group for concentrations of monocyte chemo-
attractant protein-1 (MCP-1; 100 µL/sample) 
and interleukin-8 (IL-8; 50 µL/  sample) in 
triplicate using a rat MCP-1 ELISA kit (Ray 
Biotech, Norcross, GA) or a Quantikine Rat 
CXCL1/CINC-1 ELISA kit (R&D Systems) as 
directed by the manufacturer.
Statistical analysis. Values are expressed 
as mean ± SD obtained from at least three 
separate experiments in each group. Data were 
assessed by one- or two-way analysis of vari-
ance (ANOVA). When ANOVA indicated Reynolds et al.
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significant differences, the Student t-test was 
used with Bonferroni correction for multiple 
comparisons. Results presented are representa-
tive, and those with p-values < 0.05 were con-
sidered significant. We used S-Plus 8 (Tibco 
Software, Palo Alto, CA) to analyze the data.
Results
DPM induces RAGE mRNA and protein in 
R3/1 cells and SAECs. To determine whether 
RAGE is up-regulated by exposure to DPM, 
we assessed RAGE mRNA levels in R3/1 cells 
and SAECs by quantitative real-time RT-PCR 
and compared cells exposed to DPM or fresh 
media. Compared with cells grown in cul-
ture media alone, exposure to DPM for 2 hr 
induced a significant 100% increase in RAGE 
mRNA expression (Figure 1). To determine 
possible correlation between RAGE mRNA 
and protein expression, we performed 
immunoblotting to evaluate relative concen-
trations of RAGE protein. Immunoblot anal-
ysis revealed an anticipated augmentation in 
RAGE protein expression in freshly lysed cells 
exposed to DPM for 2 hr compared with cells 
grown in the absence of DPM (Figure 2). 
Furthermore, RAGE was diminished in cells 
that were transfected with siRAGE before 
DPM exposure (Figure 2).
RAGE contributes to DPM-induced 
NF-κB activity. Because respiratory epithelial 
cells exposed to DPM resulted in significant 
RAGE up-regulation, we sought to uncover 
possible downstream signaling events in cells 
with increased RAGE. Accordingly, we per-
formed gene reporter experiments to assess 
NF-κB activity in R3/1 cells exposed to DPM. 
Exposure to DPM 24 hr after transfection of 
NF-κB–luciferase reporters revealed that R3/1 
cells initiate significant nuclear translocation 
of NF-κB compared with cells without DPM 
exposure (Figure 3). Additional experiments 
revealed that cells transfected with siRAGE 
before DPM stimulation experienced complete 
inhibition of NF-κB activity   attributed to 
DPM exposure. Specifically, nuclear trans-
location and activation of NF-κB in DPM-
exposed siRAGE transfected cells were not 
significantly different from siControl-
  transfected cells maintained without DPM 
exposure (Figure 3).
To further investigate the significance 
of RAGE abrogation by siRNA and result-
ing activation and nuclear translocation of 
NF-κB after DPM exposure, we performed 
immunostaining for active NF-κB (data not 
shown). In cells transfected with siControl, 
immunostaining revealed prominent cytoso-
lic localization of NF-κB; however, stimula-
tion of siControl-transfected R3/1 cells with 
DPM resulted in marked nuclear localization 
of NF-κB. When we transfected cells with 
siRAGE before DPM exposure, we detected 
sequestration of NF-κB in the cytoplasm 
compared with siControl transfected cells 
incubated with DPM. A no primary staining 
control (staining without NF-κB antibody) 
demonstrated antibody immunospecificity. 
Assessment of prominent cytoplasmic ver-
sus nuclear NF-κB immunostaining via ran-
domized cell counts revealed that siRAGE 
prevented significant DPM-induced NF-κB 
translocation to the nucleus (Table 1).
DPM-induced proinflammatory cytokine 
secretion is mediated by RAGE. After the 
discovery that nuclear translocation of active 
NF-κB in R3/1 cells exposed to DPM is 
mediated at least in part by RAGE, we 
designed additional experiments to evaluate 
cytokine secretion. The addition of DPM 
to R3/1 cells for 2 hr resulted in increased 
secretion of MCP-1 and IL-8, two proinflam-
matory cytokines secreted by epithelial cells 
and known transcriptional targets of NF-κB 
(Figure 4). Notably, cells transfected with 
siRAGE before DPM exposure resulted in sig-
nificantly diminished MCP-1 and IL-8 elabo-
ration compared with siControl-transfected 
cells exposed to DPM.
Discussion
DPM up-regulates RAGE mRNA and pro-
tein. Research performed previously in this 
laboratory revealed that RAGE functions 
during PM exposure. Specifically, data dem-
onstrated that cigarette smoke PM causes sig-
nificant induction of both RAGE and Egr-1 
(early growth response gene-1), a zinc-finger– 
containing transcription factor that influences 
cell responses to stimuli including cytokines, 
apoptosis-promoting factors, and injury 
(Beckmann and Wilce 1997; O’Donovan 
et al. 1999). Additional research clarified 
transcriptional control of RAGE by Egr-1 and 
the likelihood of a profound positive feed-
back loop wherein smoke-induced RAGE 
expression is further augmented by transcrip-
tional up-regulation of the receptor by Egr-1 
(Reynolds et al. 2006). Because there is a clear 
function for RAGE in cigarette-smoke–related 
PM exposure, we hypothesized that the role 
of RAGE as a pattern recognition receptor 
also includes the orchestration of inflamma-
tion resulting from other forms of fine PM, 
such as DPM.
The discovery that DPM induces RAGE 
mRNA and protein in immortalized alveolar 
epithelium is, by nature, associated with a 
restriction in extrapolation to in vivo human 
settings. However, similar observations 
in human SAECs suggest that RAGE up- 
regulation is likely associated with cellular 
responses to DPM exposure. Although con-
ventional thought stipulates that fresh DPM 
must contain ultrafine organic PM, includ-
ing polycyclic aromatic hydrocarbons and 
Figure 1. RAGE mRNA was induced by DPM in R3/1 
cells and SAECs. Quantitative real-time RT-PCR 
revealed a significant increase in RAGE mRNA 
expression in R3/1 cells and SAECs exposed to 
3 µg/mL DPM for 2 hr compared with unstimulated 
control cells. Experiments were performed in tri-












































Figure 2. RAGE protein was induced by DPM in R3/1 cells and SAECs. Immunoblotting for RAGE revealed a 
marked increase in RAGE protein synthesis in cells transfected with siControl 24 hr before a 2 hr exposure 
to 3 µg/mL DPM. Densitometry of bands revealed clear reductions in DPM-induced RAGE expression when 
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quinones, to be biologically active (Wichmann 
2007), our data suggest that aged DPM is 
not inert but is capable of biological activity. 
Because aged DPM is abundantly suspended 
in the atmosphere, these studies provide 
important observations from the standpoint 
of public health. Evidence further suggests 
that organic compounds associated with 
DPM are capable of adverse effects via redox 
reactions, culminating in the generation of 
intracellular reactive oxygen species (Li et al. 
2003; Shinyashiki et al. 2009). Furthermore, 
because ligand prevalence induces RAGE 
expression (Schmidt et al. 2001), RAGE acti-
vation by DPM may also occur because of 
the presence of AGE moieties on combusted 
DPM. The chemistry associated with the 
burning of cigarettes leads to the formation 
of AGE products detected in cigarette smoke 
(Cerami et al. 1997; Dickerson and Janda 
2002; Nicholl and Bacala 1998). Although 
it has not been fully explored, it is likely 
that diesel combustion, like the burning of 
tobacco, will also produce oxidation products 
and stable AGEs because of the facilitation of 
AGE chemistry by lower temperatures attrib-
uted to diesel engines.
Although the correlation between DPM 
inhalation and pulmonary inflammation is well 
established (Salvi et al. 2000), understanding 
the intricate mechanisms involved in perpetu-
ating DPM-mediated inflammatory responses 
has been enigmatic. Because inhalation of 
DPM directly exposes airway and alveolar epi-
thelium to harmful constituents, understanding 
the biology of stimulated epithelial cells, a sig-
nificant source of proinflammatory mediators, 
is essential. RAGE up-regulation by DPM may 
provide additional receptors necessary in first-
response mechanisms associated with epithelial 
cells positioned at the interface between inhaled 
air and lung parenchyma. Recent research 
supporting the concept of increased receptor 
availability considers the role of RAGE and 
its ligands in the effects of exposure to PM 
derived by fossil fuel combustion and the pos-
sible exacerbation of debilitating pulmonary 
disorders such as asthma and COPD (Campo 
et al. 2008; Ferhani et al. 2010; Halayko and 
Ghavami 2009).
DPM induces RAGE-mediated activation 
of NF-κB and cytokine secretion. In cells with 
differentially regulated RAGE expression, we 
assessed NF-κB after DPM exposure to evalu-
ate a proposed RAGE-mediated proinflamma-
tory pathway. NF-κB was initially identified 
as a transcription factor in B cells and has 
since been ubiquitously detected in the cyto-
plasm of all cell types (Aggarwal 2004). When 
activated by one of a host of different stimuli, 
NF-κB translocates to the nucleus, where it 
regulates the expression of more than 200 
genes that influence cell growth, survival, and 
inflammation (Aggarwal 2004). Although 
an association between DPM exposure and 
the activation of factors such as NF-κB and 
activator-protein-1 (a transcription factor) has 
been established (Takizawa et al. 1999), the 
present investigation supports the notion that 
increased availability of RAGE is important 
in DPM-mediated NF-κB activation during 
an inflammatory response. Despite this novel 
discovery, additional research that evaluates 
acute pathways of DPM-mediated pulmo-
nary inflammation initiated by RAGE liga-
tion is necessary. Such a comprehensive study 
requires assessment of RAGE and subsequent 
intracellular signal transduction involving 
NF-κB and its upstream stress-related kinases, 
including mitogen-activated protein kinases, 
p38, and c-jun N-terminal kinases (Dourazar 
et al. 2005).
Our studies revealed increases in the syn-
thesis and secretion of IL-8 and MCP-1 by 
alveolar epithelium after exposure to DPM. 
IL-8 is a CXC chemokine that predominantly 
influences neutrophil chemotaxis. Because 
of its remarkable stability, IL-8 can maintain 
prolonged biological activity despite changes 
in physiological homeostasis (Baggiolini 
and Clark-Lewis 1992). MCP-1 is a small 
cytokine belonging to the CC family of 
chemokines that activates monocytes, lym-
phocytes, mast cells, eosinophils, and baso-
phils (Oppenheim et al. 1991). The present 
data reveal that, compared with nonexposed 
controls, RAGE targeting by siRAGE can-
not alone completely inhibit DPM-induced 
IL-8 and MCP-1 secretion. However, a sig-
nificant reduction in DPM-induced cytokine 
elaboration by cells with diminished RAGE 
compared with control cells exposed to DPM 
remains noteworthy. These findings strongly 
suggest that RAGE signaling is important in 
the release of inflammatory mediators but that 
other factors and pathways are also involved. 
Despite significant RAGE-mediated reduc-
tions in the inflammatory status of epithelial 
cells, the complete inflammatory profile of 
cells exposed to DPM is likely maintained by 
a complex array of molecules functioning in 
different yet parallel pathways.
Although the amplitude of IL-8 and 
MCP-1 induction by DPM and the degree of 
prevented cytokine secretion by siRAGE trans-
fected cells were not extremely large, individual 
Figure 3. RAGE inhibition by siRNA blocked acti-
vation of NF-κB by DPM in R3/1 cells. R3/1 cells 
were transfected with an NF-κB–Luc vector and 
siRAGE or siControl 24 hr before DPM exposure or 
fresh medium replacement. Exposure to DPM for 2 
hr significantly induced nuclear NF-κB activity in 
siControl-transfected R3/1 cells. When siRAGE was 
incorporated, DPM-induced NF-κB activity was 
markedly decreased to below unstimulated basal 

































Figure 4. DPM-induced secretion of MCP-1 and IL-8 was mediated by RAGE. (A) ELISAs demonstrate that 
R3/1 cells exposed to DPM for 2 hr significantly increased MCP-1 secretion. Compared with control cells 
exposed to DPM, siRAGE incorporation significantly decreased DPM-induced MCP-1 secretion. (B) IL-8 
was significantly up-regulated by R3/1 cells after DPM exposure, and secretion of IL-8 was significantly 



























































































Table 1. Percentage of cells with compartmentalized NF-κB localization (mean ± SD).
Compartment siControl siControl + DPM siRAGE siRAGE + DPM
Percent cytoplasmic 89.3 ± 8.9 43.8 ± 8.5 83.6 ± 6.3 62.6 ± 5.7*
Percent nuclear 12.6 ± 5.2 58.3 ± 4.8 19.7 ± 7.3 41.5 ± 6.2*
*p < 0.05 compared with siControl + DPM.Reynolds et al.
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replicates were tightly grouped and reproduc-
ible. It remains plausible that secretion of IL-8 
and MCP-1 after only 2 hr of DPM expo-
sure serves as an initial response necessary in 
the activation of subsequent intermediates in 
inflammatory cascades. Continuous release of 
IL-8 and MCP-1, even at very low levels, could 
also assist in the recruitment of additional 
immune-competent cells such as lymphocytes 
and macrophages. Additional inflammatory 
mediators may then lead to the amplification of 
the initial trigger commenced by IL-8, MCP-1, 
and other early modulators. An example of this 
potential paradigm is apparent in studies that 
analyze bronchoalveolar lavage (BAL) fluid in 
patients with chronic bronchitis. BAL fluid 
obtained from affected individuals revealed 
that MCP-1 levels are significantly elevated 
compared with healthy controls despite the 
observation that initial MCP-1 induction is 
modest (Capelli et al. 1999). It is likely that 
high concentrations of MCP-1 and other early 
cytokines are not necessary when recruiting 
competent immune cells capable of profound 
proinflammatory effects.
Conclusions
In this study we report additional biological 
information regarding RAGE-mediated sig-
naling pathways activated by DPM, a near 
ubiquitous, pervasive environmental contami-
nant. Here we provide evidence that alveolar 
epithelial cells exposed to DPM significantly 
increased RAGE mRNA and protein synthe-
sis. Furthermore, DPM-induced activation 
of NF-κB and the secretion of two NF-κB 
targets, IL-8 and MCP-1, were significantly 
influenced by RAGE signaling. Together, 
these data reveal for the first time that RAGE 
signaling may be involved in inflamma-
tory responses triggered by DPM exposure. 
Although we demonstrate that RAGE target-
ing blocks DPM-induced NF-κB activity, 
understanding the role and efficacy of RAGE 
and other parallel pathways in attenuating 
inflammatory responses elicited by DPM 
is critically necessary. Currently, important 
extensions of this research seek to evaluate the 
role of RAGE in other pulmonary cell types 
and mouse models exposed to DPM. Further 
studies may demonstrate that RAGE is a pos-
sible target in the successful pharmacological 
treatment of DPM-exacerbated chronic lung 
diseases such as COPD and asthma.
RefeRences
Aggarwal BB. 2004. Nuclear factor-kappaB: the enemy within. 
Cancer Cell 6:203–208.
Baggiolini M, Clark-Lewis I. 1992. Interleukin-8, a chemotactic 
and inflammatory cytokine. FEBS Lett 307:97–101.
Bayram H, Ito K, Issa R, Ito M, Sukkar M, Churg KF. 2006. 
Regulation of human lung epithelial cell numbers by diesel 
exhaust particles. Eur Resp J 27:705–713.
Beckmann AM, Wilce PA. 1997. Egr transcription factors in the 
nervous system. Neurochem Int 31:477–510.
Buckley ST, Ehrhardt C. 2010. The receptor for advanced glyca-
tion end products (RAGE) and the lung. J Biomed Biotechnol; 
doi: 10.1155/2010/917108 [Online 19 January 2010].
Campo I, Morbini P, Pozzi E, Luisetti M. 2008. AGE receptor: a 
novel proinflammatory pathway for chronic respiratory 
disorders. Recenti Prog Med 99(5):271–278.
Capelli A, Di Stefano A, Gnemmi I, Balbo P, Cerutti CG, Balbi B, et al. 
1999. Increased MCP-1 and MIP-1beta in bronchoalveolar 
lavage fluid of chronic bronchitics. Eur Respir J 14:160–165.
Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten 
S, et al. 1997. Tobacco smoke is a source of toxic reactive gly-
cation products. Proc Natl Acad Sci U S A 94:13915–13920.
Churg A, Brauer M. 1997. Human lung parenchyma retains 
PM2.5. Am J Respir Crit Care Med 155:2109–2111.
Demling N, Ehrhardt C, Kasper M, Laue M, Knels L, Rieber EP. 
2006. Promotion of cell adherence and spreading: a novel 
function of RAGE, the highly selective differentiation 
marker of human alveolar epithelial type I cells. Cell Tissue 
Res 323:475–488.
Dickerson TJ, Janda KD. 2002. A previously undescribed chem-
ical link between smoking and metabolic disease. Proc 
Natl Acad Sci U S A 99:15084–15088.
Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME. 
1993. An association between air pollution and mortality in 
six U.S. cities. 1993. N Engl J Med 329:1753–1759.
Dourazar J, Mudway IS, Samet JM, Helleday R, Blomberg A, 
Wilson SJ, et al. 2005. Diesel exhaust activates redox-sen-
sitive transcription factors and kinases in human airways. 
Am J Physiol Lung Cell Mol Physiol 289:L1724–L1730.
Dreher KL. 2000. Particulate matter physiochemistry and toxi-
cology: in search of causality—a critical perspective. 
Inhal Toxicol 12(suppl):45–57.
Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, 
Maret M, et al. 2010. Expression of high-mobility group box 
1 and of receptor for advanced glycation end products in 
chronic obstructive pulmonary disease. Am J Respir Crit 
Care Med 181:917–927.
Halayko AJ, Ghavami S. 2009. S100A8/A9: a mediator of severe 
asthma pathogenesis and morbidity? Can J Physiol 
Pharmacol 87:743–755.
Hales S, Salmond C, Town GI, Kjellstrom T, Woodward A. 2000. 
Daily mortality in relation to weather and air pollution in 
Christchurch, New Zealand. 2000. Aust NZ J Public Health 
24:89–91.
Harre ES, Price PD, Ayrey RB, Toop LJ, Martin IR, Town GI. 
1997. Respiratory effects of air pollution in chronic obstruc-
tive pulmonary disease: a three month prospective study. 
Thorax 52:1040–1044.
Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. 1999. 
RAGE mediates a novel proinflammatory axis: a central 
cell surface receptor for S100/calgranulin polypeptides. 
Cell 97:889–901.
Kim CS, Fisher DM, Lutz DJ, Gerrity TR. 1994. Particle deposi-
tion in bifurcating airway models with varying airway 
geometry. J Aerosol Sci 25:567–581.
Koslowski R, Barth K, Augstein A, Tschernig T, Bargsten G, 
Aufderheide M, et al. 2004. A new rat type I-like alveolar 
epithelial cell line R3/1: bleomycin effects on caveolin 
expression. Histochem Cell Biol 121:509–519.
Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, et al. 2003. 
Ultrafine particulate pollutants induce oxidative stress and 
mitochondrial damage. Environ Health Perspect 111:455–460.
Ling SH, van Eden SF. 2009. Particulate matter air pollution 
exposure: role in the development and exacerbation of 
COPD. Int J Chron Obstruct Pulmon Dis 4:233–243.
National Institute of Standards and Technology. 2000. SRM 
1975: Diesel Particulate Extract. Gaithersburg, MD:U.S. 
Department of Commerce.
Nicholl ID, Bacala R. 1998. Advanced glycation endproducts 
and cigarette smoking. Cell Mol Biol 44:1025–1033.
O’Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. 
1999. The EGR family of transcription-regulatory factors: 
progress at the interface of molecular and systems neuro-
science. Trends Neurosci 22:167–173.
Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. 1991. 
Properties of the novel proinflammatory supergene “inter-
crine” cytokine family. Annu Rev Immunol 9:617–648.
Pope CA III, Thun MJ, Namboodiri MM, Dochery DW, Evans JS, 
Speizer FE, et al. 1995. Particulate air pollution as a predic-
tor of mortality in a prospective study of U.S. adults. Am J 
Respir Crit Care Med 15(3 Pt 1):669–674.
Reynolds PR, Cosio MG, Hoidal JR. 2006. Cigarette smoke induced 
Egr-1 upregulates proinflammatory cytokines in pulmonary 
epithelial cells. Am J Respir Cell Mol Biol 35:314–319.
Reynolds PR, Kasteler S, Cosio MG, Sturrock A, Huecksteadt TP, 
Hoidal JR. 2008. RAGE: developmental expression and posi-
tive feedback regulation by Egr-1 during cigarette smoke 
exposure in pulmonary epithelial cells. Am J Physiol Lung 
Cell Mol Physiol 294:L1094–L1101.
Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. 
2004. Midkine is regulated by hypoxia and causes pulmonary 
vascular remodeling. J Biol Chem 279:37124–37132.
Salvi SS, Nordenhall C, Blomberg A, Rudell B, Pourazar J, 
Kelly FJ, et al. 2000. Acute exposure to diesel exhaust 
increases IL-8 and GRO-alpha production in healthy human 
airways. Am J Respir Crit Care Med 161(2 Pt 1):550–557.
Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, 
et al. 1992. Isolation and characterization of two binding 
proteins for advanced glycosylation end products from 
bovine lung which are present on the endothelial cell sur-
face. J Biol Chem 267:14987–14997.
Schmidt AM, Yan SD, Yan SF, Stern DM. 2001. The multiligand 
receptor RAGE as a progression factor amplifying immune 
and inflammatory responses. J Clin Invest 108:949–955.
Schwartz J. 1995. Short-term fluctuations in air pollution and 
hospital admissions of the elderly for respiratory disease. 
Thorax 50:531–538.
Shinyashiki M, Eiguren-Fernandez A, Schmitz DA, Di Stefano E, 
Li N, Linak WP, et al. 2009. Electrophilic and redox proper-
ties of diesel exhaust particles. Environ Res 109:239–244.
Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, et al. 
2000. Blockade of RAGE-amphoterin signalling suppresses 
tumor growth and metastases. Nature 405:354–360.
Takizawa H, Ohtoshi T, Kawasaki S, Kohyama T, Desaki M, 
Kasama T, et al. 1999. Diesel exhaust particles induce 
NF-kappa B activation in human bronchial epithelial cells 
in vitro: importance in cytokine transcription. J Immunol 
162:4705–4711.
Thornally PJ. 1998. Cell activation by glycated proteins. AGE 
receptors, receptor recognition factors and functional classi-
fication of AGEs. Cell Mol Biol (Noisy-le-grand) 44:1013–1023.
Wichmann HE. 2007. Diesel exhaust particles. Inhal Toxicol 
19(suppl 1):241–244.
Wright ME, Klein AD, Stesniak EJ. 1991. A Diesel Exhaust Filter 
System for Industrial Diesel Forklifts. SAE Technical Paper 
Series 911852. Warrendale, PA:SAE International.
Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. 1996. RAGE 
and amyloid-beta peptide neurotoxicity in Alzheimer’s 
  disease. Nature 382:685–691.